210 related articles for article (PubMed ID: 32671950)
21. Potential drug-drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey.
Tinggaard M; David KP; Gerstoft J; Hansen AE; Kirk O; Lebech AM; Lindhardt BØ; Rose MV; Ryom L; Weis N; Benfield T
HIV Med; 2023 Jan; 24(1):46-54. PubMed ID: 35521975
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of the potential drug-drug interactions between pangenotypic direct-acting antivirals and the concomitant medications associated with patients with chronic hepatitis C virus infection in Spain.
Sicras Mainar A; Navarro Artieda R; Hernández I; Morillo R
Gastroenterol Hepatol; 2019 Oct; 42(8):465-475. PubMed ID: 31451229
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.
Moore HN; Mao L; Oramasionwu CU
AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and management of drug-drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study.
Schlaeppi C; Vanobberghen F; Sikalengo G; Glass TR; Ndege RC; Foe G; Kuemmerle A; Paris DH; Battegay M; Marzolini C; Weisser M;
HIV Med; 2020 Jan; 21(1):53-63. PubMed ID: 31532898
[TBL] [Abstract][Full Text] [Related]
25. Retrospective analysis of comorbidities and treatment burden among patients with HIV infection in a US Medicaid population.
DerSarkissian M; Bhak RH; Oglesby A; Priest J; Gao E; Macheca M; Sharperson C; Duh MS
Curr Med Res Opin; 2020 May; 36(5):781-788. PubMed ID: 31944138
[No Abstract] [Full Text] [Related]
26. Trends in Utilization of Statin Therapy and Contraindicated Statin Use in HIV--Infected Adults Treated With Antiretroviral Therapy From 2007 Through 2015.
Rosenson RS; Colantonio LD; Burkholder GA; Chen L; Muntner P
J Am Heart Assoc; 2018 Dec; 7(24):e010345. PubMed ID: 30526249
[TBL] [Abstract][Full Text] [Related]
27. Polypharmacy among HIV infected people aged 50 years or older.
Fernández Cañabate S; Ortega Valín L
Colomb Med (Cali); 2019 Sep; 50(3):142-152. PubMed ID: 32284660
[TBL] [Abstract][Full Text] [Related]
28. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens.
Patel N; Abdelsayed S; Veve M; Miller CD
Ann Pharmacother; 2011 Mar; 45(3):317-24. PubMed ID: 21386025
[TBL] [Abstract][Full Text] [Related]
29. Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis.
Hsu PY; Wei YJ; Lee JJ; Niu SW; Huang JC; Hsu CT; Jang TY; Yeh ML; Huang CI; Liang PC; Lin YH; Hsieh MY; Hsieh MH; Chen SC; Dai CY; Lin ZY; Chen SC; Huang JF; Chang JM; Hwang SJ; Chuang WL; Huang CF; Chiu YW; Yu ML
Clin Mol Hepatol; 2021 Jan; 27(1):186-196. PubMed ID: 33317251
[TBL] [Abstract][Full Text] [Related]
30. Pharmacotherapeutic profile, polypharmacy and its associated factors in a cohort of people living with HIV in Brazil.
da Silva RPN; Marins LMS; Guaraldo L; Luz PM; Cardoso SW; Moreira RI; Oliveira VDG; Veloso VG; Grinsztejn B; Estrela R; Torres TS
AIDS Res Ther; 2023 Aug; 20(1):57. PubMed ID: 37605195
[TBL] [Abstract][Full Text] [Related]
31. Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection.
Seden K; Gibbons S; Marzolini C; Schapiro JM; Burger DM; Back DJ; Khoo SH
PLoS One; 2017; 12(3):e0173509. PubMed ID: 28334018
[TBL] [Abstract][Full Text] [Related]
32. Using computer-based monitoring and intervention to prevent harmful combinations of antiretroviral drugs in the New York State AIDS Drug Assistance Program.
Gonzalez CJ; Rivera CA; Martin RJ; Mergian GA; Cruz H; Agins BD
Jt Comm J Qual Patient Saf; 2012 Jun; 38(6):269-76. PubMed ID: 22737778
[TBL] [Abstract][Full Text] [Related]
33. Recognition and management of clinically significant drug-drug interactions between antiretrovirals and co-medications in a cohort of people living with HIV in rural Tanzania: a prospective questionnaire-based study.
Kuemmerle A; Sikalengo G; Vanobberghen F; Ndege RC; Foe G; Schlaeppi C; Burri C; Battegay M; Paris DH; Glass TR; Weisser M; Marzolini C;
J Antimicrob Chemother; 2021 Sep; 76(10):2681-2689. PubMed ID: 34337653
[TBL] [Abstract][Full Text] [Related]
34. Comorbidity and polypharmacy among people with HIV stratified by age, sex, and race.
Paudel M; Prajapati G; Buysman EK; Goswami S; McNiff K; Kumar P; Tadese BK
HIV Res Clin Pract; 2024 Dec; 25(1):2361176. PubMed ID: 38869017
[No Abstract] [Full Text] [Related]
35. [Predictive factors of clinically significant drug-drug interactions among regimens based on protease inhibitors, non-nucleoside reverse transcriptase inhibitors and raltegravir].
Cervero M; Torres R; Jusdado JJ; Pastor S; Agud JL
Med Clin (Barc); 2016 Apr; 146(8):339-45. PubMed ID: 26971988
[TBL] [Abstract][Full Text] [Related]
36. Does polypharmacy affect treatment outcomes of people living with HIV starting antiretroviral therapy?
Khawcharoenporn T; Tanslaruk V
Int J STD AIDS; 2020 Oct; 31(12):1195-1201. PubMed ID: 32928055
[TBL] [Abstract][Full Text] [Related]
37. Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study.
Nozza S; Malagoli A; Maia L; Calcagno A; Focà E; De Socio G; Piconi S; Orofino G; Cattelan AM; Celesia BM; Gervasi E; Guaraldi G;
J Antimicrob Chemother; 2017 Oct; 72(10):2879-2886. PubMed ID: 28605493
[TBL] [Abstract][Full Text] [Related]
38. Impact of polypharmacy on antiretroviral prescription in people living with HIV.
Guaraldi G; Menozzi M; Zona S; Calcagno A; Silva AR; Santoro A; Malagoli A; Dolci G; Mussi C; Mussini C; Cesari M; Khoo SH
J Antimicrob Chemother; 2017 Feb; 72(2):511-514. PubMed ID: 27834193
[TBL] [Abstract][Full Text] [Related]
39. An evaluation of antiretroviral HIV/AIDS treatment in a Rio de Janeiro public clinic.
Carmody ER; Diaz T; Starling P; dos Santos AP; Sacks HS
Trop Med Int Health; 2003 May; 8(5):378-85. PubMed ID: 12753630
[TBL] [Abstract][Full Text] [Related]
40. Management of Polypharmacy and Drug-Drug Interactions in HIV Patients: A 2-year Experience of a Multidisciplinary Outpatient Clinic.
Gervasoni C; Formenti T; Cattaneo D
AIDS Rev; 2019; 21(1):40-49. PubMed ID: 30899119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
